News and Trends 12 Oct 2017
No More Seasonal Flu Shots: British Biotech’s Universal Antiviral Raises £13M
VirionHealth kicks off the development of a broad spectrum antiviral for all influenza strains and other viruses like RSV with a £13M investment in Series A. VirionHealth is developing a new type of antiviral therapy with the potential to target multiple types of viruses at once. The treatment is based on natural antivirals called defective interfering viruses. They consist […]